# Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

> **NCT01788228** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 50 (actual)

## Conditions studied

- Influenza
- Influenza Vaccines

## Interventions

- **BIOLOGICAL:** Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia)

## Key facts

- **NCT ID:** NCT01788228
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-22
- **Primary completion:** 2014-03-27
- **Final completion:** 2015-02-25
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01788228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01788228, "Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01788228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*